Author： Naber Dieter
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.4, 2011-03, pp. : 627-633
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
A review of olanzapine pamoate
Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 11, 2012-08 ,pp. :
Access to resources
Recommend
Drug safety evaluation of olanzapine pamoate
By Schöttle Daniel Kuhnigk Olaf Naber Dieter
Expert Opinion on Drug Safety, Vol. 12, Iss. 6, 2013-11 ,pp. :
Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia
By Bitter I. Dossenbach M.R.K. Brook S. Feldman P.D. Metcalfe S. Gagiano C.A. Furedi J. Bartko G. Janka Z. Banki C.M. Kovacs G. Breier A. for the Olanzapine HGCK Study Group
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 28, Iss. 1, 2004-01 ,pp. :